On the recordSeptember 30, 2020
You spent double, more than double, almost triple on stock buybacks over the three-years as you did on R&D.
Source
congress.govYou spent double, more than double, almost triple on stock buybacks over the three-years as you did on R&D.
Katie Porter highlights Amgen's spending on stock buybacks compared to R&D investment.
Share
More from Katie Porter
I want to have a pleasant, positive conversation … And if every question, you’re going to make up a follow-up question, then we’re never going to get there.
Running a race like this isn't easy, and coming up short is hard, but democracy is worth doing hard things for.